Clinical Trial Update: 7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication [Phase 3]

View source ↗

Summary

Phase 3 trial comparing 7-day versus 14-day vonoprazan-based triple therapy for Helicobacter pylori eradication has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis
• Helicobacter Pylori Infection

Drugs mentioned

• Vonoprazan (vonoprazan)

Snippet

Sponsor: Alexandria University | Conditions: Helicobacter Pylori Infection, Gastritis | Phase 3 | Status: COMPLETED